|Application ||WB, IHC-P, E, IP, ID, Flo|
|Calculated MW||36154 Da|
|Dilution||ELISA, Flo, ID, IHC-P (2.5 µg/ml), IP, WB|
|Other Names||APOE, AD2, Apo-E, Apolipoprotein E3, Apolipoprotein E, LDLCQ5, LPG|
|Target/Specificity||Human Apolipoprotein E|
|Reconstitution & Storage||Immunoaffinity purified|
|Precautions||Anti-APOE / Apolipoprotein E Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues.|
|Tissue Location||Occurs in all lipoprotein fractions in plasma. It constitutes 10-20% of very low density lipoproteins (VLDL) and 1-2% of high density lipoproteins (HDL). APOE is produced in most organs. Significant quantities are produced in liver, brain, spleen, lung, adrenal, ovary, kidney and muscle|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.